Quantumzyme - About the company
Quantumzyme is a seed company based in Bengaluru (India), founded in 2016. It operates as a Developer of computational tools for engineering enzymes for industrial applications. Quantumzyme has raised an undisclosed amount in funding from Ajanta Pharma Founders Family Office. The company has 68 active competitors, including 7 funded and 7 that have exited. Its top competitors include companies like BRAIN, Science Exchange and Bioz.
Company Details
Developer of computational tools for engineering enzymes for industrial applications. This organization provides biotransformation services by utilizing quantum mechanics and molecular modeling to enhance enzyme activity, selectivity, and specificity. It focuses on simplifying complex chemical processes through scientific rationale to reduce the use of hazardous substances in manufacturing. The service offerings span from initial enzyme discovery and in silico engineering to wet lab validation and process development. By applying advanced computational frameworks, the firm assists chemical companies in creating designer enzymes suitable for large-scale industrial use. These solutions support sustainable practices by optimizing biocatalytic reactions for sectors including pharmaceuticals, food processing, and textile manufacturing. The technical approach integrates structural biology and molecular dynamics to address specific biocatalysis requirements while maintaining high standards of scientific integrity and research precision.
- Website
- quantumzyme.com
- Email ID
- *****@quantumzyme.com
- Phone Number
- +91 **********
- Registered Address
- C-12,C/SF,SECOND FLOOR, OMAXE CITY CENTRE, SOHNA ROAD, Gurgaon, Gurgaon, Haryana, India, 122001
Key Metrics
Founded Year
2016
Location
Bengaluru, India
Stage
Seed
Latest Funding Round
Investors
Ranked
9th among 68 active competitors
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2024
Employee Count
9 as on Aug 31, 2026
Legal entities associated with Quantumzyme
Quantumzyme is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Impex Worldwide Cargo Services Llp CIN: AAH-4489 , India, Active | Sep 21, 2016 | 0 - ₹10 Cr (As on Mar 31, 2019) | - | |
Quantumzyme Llp CIN: AAH-4439 , India, Active | Sep 21, 2016 | 0 - ₹10 Cr (As on Mar 31, 2024) | - |
Sign up to download Quantumzyme's company profile
Quantumzyme's funding and investors
Quantumzyme has raised funding over 2 rounds. Its first funding round was on 2016. Its latest funding round was a Seed round on 2017 for $*****. 1 investor participated in its latest round. Quantumzyme has 1 institutional investor and 1 angel investor.
Here is the list of recent funding rounds of Quantumzyme:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
2017 | 3812 | Seed | 8108 | 7809 | 9385 | 5220 |
2016 | 9452 | Angel | 3053 | 1639 | 8828 |
View details of Quantumzyme's funding rounds and investors
Quantumzyme's founders and board of directors
Founder? Claim ProfileQuantumzyme's employee count trend
Quantumzyme has 9 employees as of Aug 26. Here is Quantumzyme's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Quantumzyme's Competitors and alternates
Top competitors of Quantumzyme include BRAIN, Science Exchange and Bioz. Here is the list of Top 10 competitors of Quantumzyme, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developr of bio-based products and natural compounds for biotechnological solutions | $5.38M | 68/100 | ||
2nd | Science Exchange 2011, Palo Alto (United States), Acquired | Online marketplace for outsourcing scientific research | $77.6M | 66/100 | |
3rd | Bioz 2013, Los Altos (United States), Series A | Developer of AI search engine for scientific experimentation | $17.5M | 63/100 | |
4th | Company focuses on creating biosolutions | - | 55/100 | ||
5th | Anodyne Chemistries 2021, Vancouver (Canada), Seed | Provider of immobilized enzyme complexes for green chemical production | $1M | 48/100 | |
6th | Provider of a platform focused on enzymatic recycling processes | - | 48/100 | ||
7th | Exozymes 2019, Monrovia (United States), Funding Raised | Developer of exozyme biosolutions for nutraceutical, medicine, and biofuel markets | - | 43/100 | |
8th | Infinita Biotech 2015, Vadodara (India), Unfunded | Provider of enzymatic solutions for various industries | - | - | 40/100 |
9th | Quantumzyme 2016, Bengaluru (India), Seed | Developer of computational tools for engineering enzymes for industrial applications | - | 38/100 | |
10th | ![]() Neu Elements Pvt Ltd Bengaluru (India), Unfunded | Developer of enzyme solutions for industrial applications, including grain processing | - | - | 34/100 |
Looking for more details on Quantumzyme's competitors? Click here to see the top ones
Quantumzyme's Investments and acquisitions
Quantumzyme has made no investments or acquisitions yet.
Reports related to Quantumzyme
Here is the latest report on Quantumzyme's sector:
News related to Quantumzyme
Media has covered Quantumzyme for a total of 6 events in the last 1 year, 6 of them have been about company updates.
•
•
Quantumzyme Announces Board Approval for Strategic Name Change to Quantum Genesis AINewMediaWire•Dec 01, 2025•Quantumzyme
•
Quantumzyme Ships Green Ibuprofen Lab Sample for Industrial ValidationNewMediaWire•Nov 14, 2025•Quantumzyme
•
Quantumzyme Expands AI-Driven Enzyme Platform for Green API ManufacturingNewMediaWire•Nov 11, 2025•Quantumzyme
•
Quantumzyme Announces Publication of Green Ibuprofen Process in RSC SustainabilityNewMediaWire•Nov 05, 2025•Quantumzyme
•
Quantumzyme Announces Publication of Patents Supporting Sustainable Pharmaceutical Growth & InnovationNewMediaWire•Oct 31, 2025•Quantumzyme
•
Quantumzyme Announces Removal of OTC Markets Caveat Emptor DesignationNewMediaWire•Jul 25, 2025•Quantumzyme
•
Quantumzyme Highlights Benefits and Commercialization Opportunities of Pending Breakthrough Green Chemistry PatentNewMediaWire•Apr 28, 2025•Quantumzyme
•
Quantumzyme Anticipates Publication of Transformative Patent for Enzymatic Ibuprofen ManufacturingNewMediaWire•Apr 23, 2025•Quantumzyme
•
Quantumzyme Advances Enzymatic Innovation for Sustainable IndustryNewMediaWire•Apr 11, 2025•Quantumzyme
Are you a Founder ?
FAQs about Quantumzyme
Explore our recently published companies
- SLBC Bihar - Patna based, Unfunded company
- Multi Global Unity - Indonesia based, 2014 founded, Unfunded company
- Digital Directions - Unfunded company
- TheOTCLab (B Corp) - Amsterdam based, 2016 founded, Unfunded company
- Good Guys Property Maintenance - Abbotsford based, Unfunded company
- Bronjo - Unfunded company

